Application of a high-resolution melt assay for monitoring SARS-CoV-2 variants in Burkina Faso and Kenya
mSphere · 2025
DOI: 10.1128/msphere.00027-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift mSphere, 2025. Verfasst von Caitlin Greenland-Bews und 36 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gates Foundation, Bill and Melinda Gates Foundation, National Institute for Health Research Health Protection Research Unit.
Abstract (Originalsprache)
The rapid emergence and global dissemination of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) highlighted a need for robust, adaptable surveillance systems. However, financial and infrastructure requirements for whole-genome sequencing mean most surveillance data have come from higher-resource geographies, despite unprecedented investment in sequencing in low- and middle-income countries (LMICs). Consequently, the molecular epidemiology of SARS-CoV-2 in some LMICs is limited, and there is a need for more cost-accessible technologies to help close data gaps for surveillance of SARS-CoV-2 variants. To address this, we have developed two high-resolution melt (HRM) curve assays that target variant-defining mutations in the SARS-CoV-2 genome, which give unique signature profiles that define different SARS-CoV-2 variants of concern (VOCs). Extracted RNA from SARS-CoV-2-positive samples collected from 205 participants (112 in Burkina Faso, 93 in Kenya) enrolled in the MALCOV study (Malaria as a Risk Factor for COVID-19) between February 2021 and February 2022 were analyzed using our optimized HRM assays. With next-generation sequencing on Oxford Nanopore MinION as a reference, two HRM assays, HRM-VOC-1 and HRM-VOC-2, demonstrated sensitivity/specificity of 100%/99.29% and 92.86%/99.39%, respectively, for detecting Alpha, 90.08%/100% and 92.31%/100% for Delta, and 93.75%/100% and 100%/99.38% for Omicron BA.1. The assays described here provide a lower-cost approach to conducting molecular epidemiology, capable of high-throughput testing. We successfully scaled up the HRM-VOC-2 assay to screen a total of 506 samples from which we were able to show the replacement of Alpha with the introduction of Delta and the replacement of Delta by the Omicron variant in this community in Kisumu, Kenya. IMPORTANCE The rapid evolution of the severe acute respiratory syndrome coronavirus 2 variants of concern (VOCs) demonstrated the need for accessible surveillance tools so all communities can conduct viral surveillance. Sequencing, the gold standard, is still a largely inaccessible methodology in low-resource settings. Here, we present a quick, low-cost tool to screen for the common VOCs, designed to support surveillance efforts in low-resource settings. This tool was used to screen samples from Burkina Faso and Western Kenya throughout the pandemic. We show through comparison to sequencing that our assay can generate highly similar data on the different variants circulating in a population, therefore showing the effectiveness of our tool. While not a replacement for sequencing, we present a method of screening and prioritizing samples for further investigation and reduce overburdening sequencing capacity. Our findings provide insight into one potential tool that could be further applied to pathogen screening in the absence of robust sequencing infrastructure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
- Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
- Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kisumu County, Kenya.
- Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
- Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, Gambia.
- National Heart and Lung Institute, Imperial College London, London, United Kingdom.
ORCID-Profile: Caitlin Greenland-Bews, Issiaka Soulama, David J Allen, Thomas Edwards
Förderung
- Gates Foundation
- Bill and Melinda Gates Foundation
- National Institute for Health Research Health Protection Research Unit
- U.S Food and Drug Administration Medical Countermeasures Initiative Contract
- UKPHRST
- National Environment Research Council
Zitieren
APA
Greenland-Bews, C., Shah, S., Achieng, M., Badoum, E. S., Bah, Y., Barsosio, H. C., Brazal-Monzó, H., Canizales, J., Drabko, A., Fraser, A. J., Hannan, L., Jarju, S., Kaboré, J. M., Kujabi, M. A., Leggio, C., Lesosky, M., Manneh, J., Marlais, T., Matthewman, J., …, & Edwards, T. (2025). Application of a high-resolution melt assay for monitoring SARS-CoV-2 variants in Burkina Faso and Kenya. mSphere. https://doi.org/10.1128/msphere.00027-25
Vancouver
Greenland-Bews C, Shah S, Achieng M, Badoum ES, Bah Y, Barsosio HC, et al. Application of a high-resolution melt assay for monitoring SARS-CoV-2 variants in Burkina Faso and Kenya. mSphere. 2025. doi:10.1128/msphere.00027-25
BibTeX
@article{GreenlandBews2025,
author = {Greenland-Bews, Caitlin and Shah, Sonal and Achieng, Morine and Badoum, Emilie S and Bah, Yaya and Barsosio, Hellen C and Brazal-Monzó, Helena and Canizales, Jennifer and Drabko, Anna and Fraser, Alice J and Hannan, Luke and Jarju, Sheikh and Kaboré, Jean-Moise and Kujabi, Mariama A and Leggio, Cristina and Lesosky, Maia and Manneh, Jarra and Marlais, Tegwen and Matthewman, Julian and Nebié, Issa and Onyango, Eric and Ouedraogo, Alphonse and Otieno, Kephas and Serme, Samuel S and Sirima, Sodiomon and Soulama, Ben and Tangara, Brian and Tiono, Alfred and Wu, William and Adams, Emily R and Sesay, Abdul Karim and Drakeley, Chris and Ter Kuile, Feiko O and Soulama, Issiaka and Kariuki, Simon and Allen, David J and Edwards, Thomas},
title = {Application of a high-resolution melt assay for monitoring SARS-CoV-2 variants in Burkina Faso and Kenya},
journal = {mSphere},
year = {2025},
doi = {10.1128/msphere.00027-25}
}
EUVIMED